Acorai, founded by a seasoned team of innovators, has created a first-of-its[1]kind non-invasive Intracardiac Pressure Monitor ▪ It matters because it is the only way to safely, accurately and cost[1]efficiently manage heart failure patients to improve quality of care ▪ Heart Failure affects more than 60 million people and costs >€300Bn globally ▪ Hospitals will …
ree from wearables and wires Donisi is the only clinically validated contact-free technology that can identify increased lung fluid content at home. Our easy-to-use devices are based upon FDA-cleared technology and backed up by 11 granted patents. Helping to optimize the continuum of care and improve lives for people with CHF and other chronic diseases, …
VDyne, Inc. is developing the VDyne Transcatheter Tricuspid Valve Replacement System for the percutaneous treatment of tricuspid valve regurgitation. Tricuspid valve regurgitation is prevalent and carries an increased incidence of morbidity and mortality. The VDyne system is a “true-fit” design, specifically for the tricuspid valve. It’s novel side delivery approach is designed to facilitate simple …
Healium Medical is a privately held Yokneam, Israel based medical device company focused on advancing atrial fibrillation therapy – the most common cardiac arrhythmia affecting millions of patients worldwide. The company develops ultrasound technology enabling rapid, contactless circumferential pulmonary vein isolation with real-time lesion monitoring using a single catheter platform to improve procedure efficacy, simplify …
AuriGen Medical is an Irish electrophysiology and structural heart company committed to transforming the management of persistent atrial fibrillation by developing the first cardiac implant to treat both the stroke and arrhythmia risk associated with this devastating condition. Everyday millions of patients suffer with atrial fibrillation, a condition characterized by an irregular heartbeat or arrhythmia …
BioGenCell has developed a long-term road map for the next five years and beyond. Our goal is to reach commercialization of the first product based on FDA’s and EMA’s expedited programs while developing a pipeline of additional products based on our technology platform. A phase I/II multi-centered randomized-controlled-study in 40 patients was approved in Israel …
EyeFree Assisting Communications Ltd. aims to be a leading supplier of assistive communication devices for the “locked-in” community. This community is represented by ALS and other patients who have lost their ability to communicate, but still have fully functioning cognitive abilities. A subset of this community is others that may be temporarily “locked-in” due to …
Vigor Medical Technologies Ltd., is a private Israeli company, developing innovative medical devices in the field of critical care. Our flagship product, C-Lant Port, is a life saving device for effective treatment of any type of chest trauma (blunt or penetrating) or for post operative drainage following major thoracic and abdominal procedures. C-Lant’s feasibility and …
Nuheart was established in March 2014 and is dedicated to developing a novel concept for a heart pump treatment, from idea to clinical use. The Nuheart device represents the first percutaneous ventricular assist device (VAD) able to provide complete, long-term circulatory support for patients with severe heart failure. The Nuheart VAD will have the key …